Latest news with #GautamPatel
Yahoo
11 hours ago
- Business
- Yahoo
Analysts Bullish as Amneal Pharmaceuticals, Inc. (AMRX) Director Sells Over 94K Shares
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is among the best growth stocks to invest in for the next 5 years. Gautam Patel, the director of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX), sold 94,906 shares of Class A Common Stock, worth around $761,146, on June 16, 2025. The prices fluctuated between $8.00 and $8.05 per share, while the current trading price stands at $7.92. As a result of the transaction, Patel's stake now amounts to 1,609,144 shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX). The sale was executed automatically in accordance with a pre-determined trading plan adopted on August 15, 2024, and in compliance with Rule 10b5-1(c). In general, analysts remain optimistic regarding the stock, with price targets ranging between $11 and $12 per share. A pharmaceutical laboratory filled with shelves of medicines, highlighting the company's specialty drug production. Just recently, analysts at Goldman Sachs reviewed the generic drug industry and initiated coverage on Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) with a positive outlook. The reasons cited were many, from current portfolio changes favoring higher-value products to the company's track record of business execution. With a 12-month price target of $12, the analyst supported the potential upside of over 50%. Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX), headquartered in Bridgewater, New Jersey, is a leading biopharmaceutical company that develops and markets generics, injectables, biosimilars, and specialty branded pharmaceutical products. Founded in 2002, the company operates through three main segments: Affordable Medicines, Specialty, and AvKARE. The giant is committed to advancing innovation in healthcare. While we acknowledge the potential of AMRX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
Indian Express
2 days ago
- Politics
- Indian Express
Express View on Karnataka's draft bill on fake news: Don't make it law
Several elements go into making legislation 'bad in law': Vague provisions and definitions that invite misuse; arrogation of power to government authorities without necessary checks and guardrails; difficulties of enforcement or possibilities of selective enforcement and, most importantly, legitimate concerns about infringement on fundamental rights and violation of due process. The Karnataka Mis-Information and Fake News (Prohibition) Bill fulfils these criteria, and more. It constitutes an 'Authority' — headed by the state Information & Broadcasting Minister and made up mostly of lawmakers and officials selected by the government — that is all but certain to act as a censor. It is a bill of bad faith — it enables an exercise of arbitrary power under the garb of rooting out falsehood. It is an overzealous government addressing a complex issue through the bluntest of instruments. India has approximately 700 million smartphone users, and Karnataka is among the states with the highest internet penetration. Can the proposed Authority mine and analyse the vast amounts of data on social media while ensuring that no citizen's right to free speech is violated? More importantly, even if it could, should it? 'Fake news' is defined by the Bill as false or inaccurate reporting, editing that distorts facts and purely fabricated content. Misinformation is 'knowingly' or 'recklessly' spreading falsehoods, with exceptions for religious sermons, satire, and 'artistic expression'. Evidently, the government of Karnataka, not satisfied with setting itself up as the arbiter of Truth, seeks to define Art as well. It also wishes to prosecute what it deems as going against 'feminism' and 'Sanatan Dharma'. The Bill compounds the sin of loosely worded and vague provisions with harsh punishment: Offenders face fines up to Rs 10 lakh, seven years' imprisonment or both. It flies in the face of the letter and spirit of the Supreme Court's judgment in the Shreya Singhal (2013) case and the Bombay High Court verdict on the Centre's IT Rules in 2024, both of which warned against the dangers of ill-defined legal provisions encroaching on free speech. India already has laws on defamation and for protecting 'hurt sentiments', which are often weaponised by governments to curb fundamental freedoms. Karnataka's capital is a hub of innovation, and of a start-up culture that has the potential to propel the state's and the country's economy forward. The government must recognise that innovation and censorship do not go together. Fifty years after the Emergency, the lesson on the dangers of state excess and overreach should have been internalised by Congress governments, including in Karnataka. As Justice Gautam Patel noted in the Bombay HC's 2024 verdict, 'Every attempt to whittle down a fundamental right must be resisted root and branch.' Misinformation and fake news are indeed problems of the present and future. Addressing them requires digital literacy, which involves going to schools to ensure that the next generation is equipped to sift fact from falsehood. Such programmes require finesse, time and the right intent. Not a draconian law — the Bill needs to be binned.
